Survival in an Incident Cohort of Patients with Pulmonary Arterial Hypertension in Denmark

Overview

Journal Pulm Circ

Publisher Wiley

Specialty Pulmonary Medicine

Date 2015 Jun 12

PMID 26064463

Citations 14

Authors

Kasper Korsholm

Asger Andersen

Rikke E Kirkfeldt

Knud N Hansen

Soren Mellemkjaer

Jens Erik Nielsen-Kudsk

Affiliations

Soon will be listed here.

Abstract

We aimed to characterize and estimate survival rates in patients diagnosed with pulmonary arterial hypertension (PAH) in western Denmark in the modern management era. All incident cases of PAH were consecutively enrolled in our single-center prospective cohort study between January 2000 and March 2012. A total of 134 patients fulfilling the inclusion criteria were followed up from first diagnostic right heart catheterization to either death or the end of the study. Kaplan-Meier survival analysis was used to estimate 1-, 3-, and 5-year survival rates with 95% confidence intervals (CIs). Survival in the total cohort was 86.4% (95% CI, 79.3%-91.2%) after 1 year, 72.9% (95% CI, 64.1%-79.9%) after 3 years, and 65.4% (95% CI, 55.8%-73.4%) after 5 years. Significantly better survival was seen in the group of patients with PAH associated with congenital heart disease than in the group of patients with idiopathic PAH, heritable PAH, connective tissue disease, HIV infection, and portal hypertension. In conclusion, survival rates in the Danish PAH population were similar to or slightly better than survival rates estimated in other modern registries. However, PAH remains a fatal disease, despite modern targeted therapies.

Citing Articles

Real-world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative's Real-world Evidence Working....

Morland K, Gerges C, Elwing J, Visovatti S, Weatherald J, Gillmeyer K Pulm Circ. 2023; 13(4):e12317.

PMID: 38144948 PMC: 10739115. DOI: 10.1002/pul2.12317.

Incidence and outcomes of pulmonary hypertension in the Ireland.

Cullivan S, Lennon D, Meghani S, Minnock C, McCullagh B, Gaine S BMJ Open Respir Res. 2022; 9(1).

PMID: 35768152 PMC: 9244715. DOI: 10.1136/bmjresp-2022-001272.

Prevalence, incidence, and survival of pulmonary arterial hypertension: A systematic review for the global burden of disease 2020 study.

Emmons-Bell S, Johnson C, Boon-Dooley A, Corris P, Leary P, Rich S Pulm Circ. 2022; 12(1):e12020.

PMID: 35506069 PMC: 9052982. DOI: 10.1002/pul2.12020.

Long-term outcomes in pulmonary arterial hypertension by functional class: a meta-analysis of randomized controlled trials and observational registries.

Kim N, Fisher M, Poch D, Zhao C, Shah M, Bartolome S Pulm Circ. 2020; 10(4):2045894020935291.

PMID: 33282180 PMC: 7691927. DOI: 10.1177/2045894020935291.

Cardiovascular disease in women: insights from magnetic resonance imaging.

Bucciarelli-Ducci C, Ostenfeld E, Baldassarre L, Ferreira V, Frank L, Kallianos K J Cardiovasc Magn Reson. 2020; 22(1):71.

PMID: 32981527 PMC: 7520984. DOI: 10.1186/s12968-020-00666-4.

References

Benza R, Miller D, Barst R, Badesch D, Frost A, McGoon M . An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry. Chest. 2012; 142(2):448-456. DOI: 10.1378/chest.11-1460. View

Galie N, Hoeper M, Humbert M, Torbicki A, Vachiery J, Barbera J . Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the.... Eur Heart J. 2009; 30(20):2493-537. DOI: 10.1093/eurheartj/ehp297. View

Simonneau G, Robbins I, Beghetti M, Channick R, Delcroix M, Denton C . Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2009; 54(1 Suppl):S43-S54. DOI: 10.1016/j.jacc.2009.04.012. View

Pedersen C . The Danish Civil Registration System. Scand J Public Health. 2011; 39(7 Suppl):22-5. DOI: 10.1177/1403494810387965. View

Humbert M, Sitbon O, Yaici A, Montani D, OCallaghan D, Jais X . Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension. Eur Respir J. 2010; 36(3):549-55. DOI: 10.1183/09031936.00057010. View

McLaughlin V, Davis M, Cornwell W . Pulmonary arterial hypertension. Curr Probl Cardiol. 2011; 36(12):461-517. DOI: 10.1016/j.cpcardiol.2011.08.002. View

Galie N, Torbicki A, Barst R, Dartevelle P, Haworth S, Higenbottam T . Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J. 2004; 25(24):2243-78. DOI: 10.1016/j.ehj.2004.09.014. View

Escribano-Subias P, Blanco I, Lopez-Meseguer M, Lopez-Guarch C, Roman A, Morales P . Survival in pulmonary hypertension in Spain: insights from the Spanish registry. Eur Respir J. 2012; 40(3):596-603. DOI: 10.1183/09031936.00101211. View

Simonneau G, Gatzoulis M, Adatia I, Celermajer D, Denton C, Ghofrani A . Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013; 62(25 Suppl):D34-41. DOI: 10.1016/j.jacc.2013.10.029. View

10.

Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V . Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med. 2006; 173(9):1023-30. DOI: 10.1164/rccm.200510-1668OC. View

11.

Simonneau G, Galie N, Rubin L, Langleben D, Seeger W, Domenighetti G . Clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2004; 43(12 Suppl S):5S-12S. DOI: 10.1016/j.jacc.2004.02.037. View

12.

Peacock A, Murphy N, McMurray J, Caballero L, Stewart S . An epidemiological study of pulmonary arterial hypertension. Eur Respir J. 2007; 30(1):104-9. DOI: 10.1183/09031936.00092306. View

13.

McGoon M, Kane G . Pulmonary hypertension: diagnosis and management. Mayo Clin Proc. 2009; 84(2):191-207. PMC: 2664591. DOI: 10.4065/84.2.191. View

14.

Thenappan T, Shah S, Rich S, Tian L, Archer S, Gomberg-Maitland M . Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation. Eur Respir J. 2009; 35(5):1079-87. PMC: 8782564. DOI: 10.1183/09031936.00072709. View

15.

DAlonzo G, Barst R, Ayres S, Bergofsky E, Brundage B, Detre K . Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med. 1991; 115(5):343-9. DOI: 10.7326/0003-4819-115-5-343. View

16.

Humbert M, Morrell N, Archer S, Stenmark K, MacLean M, Lang I . Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol. 2004; 43(12 Suppl S):13S-24S. DOI: 10.1016/j.jacc.2004.02.029. View